DOP2002000508A - PHARMACEUTICAL COMPOSITION - Google Patents

PHARMACEUTICAL COMPOSITION

Info

Publication number
DOP2002000508A
DOP2002000508A DO2002000508A DO2002000508A DOP2002000508A DO P2002000508 A DOP2002000508 A DO P2002000508A DO 2002000508 A DO2002000508 A DO 2002000508A DO 2002000508 A DO2002000508 A DO 2002000508A DO P2002000508 A DOP2002000508 A DO P2002000508A
Authority
DO
Dominican Republic
Prior art keywords
pharmaceutical composition
pharmaceutical
composition
Prior art date
Application number
DO2002000508A
Other languages
Spanish (es)
Inventor
Mike Yeadon
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Priority to DO2002000508A priority Critical patent/DOP2002000508A/en
Publication of DOP2002000508A publication Critical patent/DOP2002000508A/en

Links

DO2002000508A 2002-11-12 2002-11-12 PHARMACEUTICAL COMPOSITION DOP2002000508A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DO2002000508A DOP2002000508A (en) 2002-11-12 2002-11-12 PHARMACEUTICAL COMPOSITION

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DO2002000508A DOP2002000508A (en) 2002-11-12 2002-11-12 PHARMACEUTICAL COMPOSITION

Publications (1)

Publication Number Publication Date
DOP2002000508A true DOP2002000508A (en) 2003-06-15

Family

ID=44261109

Family Applications (1)

Application Number Title Priority Date Filing Date
DO2002000508A DOP2002000508A (en) 2002-11-12 2002-11-12 PHARMACEUTICAL COMPOSITION

Country Status (1)

Country Link
DO (1) DOP2002000508A (en)

Similar Documents

Publication Publication Date Title
FI20011478A0 (en) Pharmaceutical composition
PT1501534E (en) PHARMACEUTICAL FORMULATIONS
PT1467724E (en) AGOMELATIN ORODISPERSAVEL PHARMACEUTICAL COMPOSITION
EP1603593A4 (en) PHARMACEUTICAL COMPOSITION
DK1587478T3 (en) PHARMACEUTICAL COMPOSITION
PL367180A1 (en) Durable pharmaceutical composition
DK3384931T3 (en) SUPERFIN FORMOTHER FORMULATION
DE10393374D2 (en) composition
ATE380544T1 (en) COATED SOLID PHARMACEUTICAL FORM
EP1537195A4 (en) DISINFECTANT COMPOSITION
FR2862654B1 (en) FILMOGENATED AMYLACEE COMPOSITION
EP1425019A4 (en) PHARMACEUTICAL COMPOSITION
NO20050132D0 (en) vaccine Composition
SK4326U (en) Sustained-release pharmaceutical composition
EP1559433A4 (en) STABILIZED COMPOSITION
IS7051A (en) pharmaceutical compositions
DK1561472T3 (en) Solid Composition
FI20022128L (en) Pharmaceutical composition
PT1558263E (en) PROLONGED LIBERATION PHARMACEUTICAL COMPOSITION
SE0500163L (en) Composition
EP1561467A4 (en) DERMO-REPARATORY COMPOSITION
IS7581A (en) A pharmaceutical composition
NO20034952D0 (en) Pharmaceutical compounds
PL377147A1 (en) Oral composition
NO20044140D0 (en) New Composition